Trafalgar International (GCAN) Cash from Financing Activities (2017 - 2026)
Greater Cannabis Company (GCAN) posted quarterly Cash from Financing Activities of $5000.0 for Q1 2026, down 98.0% quarter-over-quarter from $250000.0 in Q2 2021.
Trafalgar International (GCAN) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $5000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities changed N/A year-over-year to $5000.0; the TTM figure through Mar 2026 stood at $255000.0 (changed N/A YoY), while the FY2025 annual figure was $3600.0, changed N/A from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $5000.0, down from $250000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $5000.0 in Q1 2026, with the low at $5000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -813.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -1.13 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 122.40 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -1.24 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 63.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -74.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Jun 30, 2021 | 250,000.00 |
| Jun 30, 2021 | 250,000.00 |
| Mar 31, 2021 | 250,000.00 |
| Mar 31, 2021 | 250,000.00 |
| Jun 30, 2020 | 13,001.00 |
| Jun 30, 2020 | 13,001.00 |
| Mar 31, 2020 | 426,667.00 |
| Mar 31, 2020 | 426,667.00 |
| Mar 31, 2019 | 250,000.00 |
| Mar 31, 2019 | 250,000.00 |
| Sep 30, 2018 | 139,217.00 |
| Sep 30, 2018 | 139,217.00 |
| Jun 30, 2018 | 20,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Mar 31, 2018 | 783.00 |
| Mar 31, 2018 | 783.00 |
| Dec 31, 2017 | 5,547.00 |
| Dec 31, 2017 | 5,547.00 |